ZA991315B - Novel substituted pyridino arylpiperazines useful in the treatment of benign prostatic hyperplasia. - Google Patents

Novel substituted pyridino arylpiperazines useful in the treatment of benign prostatic hyperplasia.

Info

Publication number
ZA991315B
ZA991315B ZA9901315A ZA991315A ZA991315B ZA 991315 B ZA991315 B ZA 991315B ZA 9901315 A ZA9901315 A ZA 9901315A ZA 991315 A ZA991315 A ZA 991315A ZA 991315 B ZA991315 B ZA 991315B
Authority
ZA
South Africa
Prior art keywords
treatment
benign prostatic
prostatic hyperplasia
novel substituted
substituted pyridino
Prior art date
Application number
ZA9901315A
Other languages
English (en)
Inventor
Gee-Hong Kuo
William V Murray
Catherine P Prouty
Original Assignee
Ortho Mcneil Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Mcneil Pharm Inc filed Critical Ortho Mcneil Pharm Inc
Publication of ZA991315B publication Critical patent/ZA991315B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81—Amides; Imides
    • C07D213/82—Amides; Imides in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
ZA9901315A 1998-02-20 1999-02-18 Novel substituted pyridino arylpiperazines useful in the treatment of benign prostatic hyperplasia. ZA991315B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US7532198P 1998-02-20 1998-02-20

Publications (1)

Publication Number Publication Date
ZA991315B true ZA991315B (en) 2000-11-20

Family

ID=22124955

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9901315A ZA991315B (en) 1998-02-20 1999-02-18 Novel substituted pyridino arylpiperazines useful in the treatment of benign prostatic hyperplasia.

Country Status (24)

Country Link
US (1) US6218396B1 (ja)
EP (1) EP1054868B1 (ja)
JP (1) JP2002503724A (ja)
KR (1) KR100591028B1 (ja)
CN (1) CN1121390C (ja)
AR (1) AR014626A1 (ja)
AT (1) ATE250580T1 (ja)
AU (1) AU766398B2 (ja)
BR (1) BR9909647A (ja)
CZ (1) CZ294136B6 (ja)
DE (1) DE69911582T2 (ja)
DK (1) DK1054868T3 (ja)
ES (1) ES2209468T3 (ja)
HK (1) HK1030776A1 (ja)
HU (1) HUP0100781A3 (ja)
IL (2) IL137954A0 (ja)
NO (1) NO317103B1 (ja)
NZ (1) NZ506462A (ja)
PL (1) PL342339A1 (ja)
PT (1) PT1054868E (ja)
TR (1) TR200003220T2 (ja)
TW (1) TW565555B (ja)
WO (1) WO1999042448A1 (ja)
ZA (1) ZA991315B (ja)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69818255T2 (de) * 1997-05-12 2004-12-23 Ortho-Mcneil Pharmaceutical, Inc. Arylsubstituierte piperazine die bei der behandlung von gutartiger prostatischer hyperlasie nützlich sind
EP1311482B1 (en) 2000-08-08 2007-02-21 Ortho-McNeil Pharmaceutical, Inc. Non-imidazole aryloxypiperidines as h3 receptor ligands
US7132547B2 (en) 2001-12-28 2006-11-07 Takeda Pharmaceutical Company Limited Preventives/remedies for urinary disturbance
US8470859B2 (en) 2006-10-23 2013-06-25 Takeda Pharmaceutical Company Limited Iminopyridine derivative and use thereof
US8481569B2 (en) 2008-04-23 2013-07-09 Takeda Pharmaceutical Company Limited Iminopyridine derivatives and use thereof
NZ588909A (en) * 2008-04-23 2012-08-31 Takeda Pharmaceutical Iminopyridine derivatives and use thereof
US20110039892A1 (en) * 2008-04-23 2011-02-17 Takeda Pharmaceutical Company Limited Iminopyridine derivative and use thereof
CN103980195A (zh) * 2014-04-28 2014-08-13 广州医科大学 酰胺类苯基哌嗪衍生物及其盐与在制备治疗良性前列腺增生症药物中的应用
CN108530391B (zh) * 2018-05-17 2022-05-17 袁牧 一种酰胺类芳基哌嗪衍生物及其制备方法与应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2027898A6 (es) * 1991-01-24 1992-06-16 Espanola Prod Quimicos Procedimiento de preparacion de nuevos derivados de la 2-metoxifenilpiperacina.
US5403847A (en) 1992-11-13 1995-04-04 Synaptic Pharmaceutical Corporation Use of α1C specific compounds to treat benign prostatic hyperlasia
IT1266582B1 (it) * 1993-07-30 1997-01-09 Recordati Chem Pharm Derivati (di)azacicloesanici e diazacicloeptanici
DE4425146A1 (de) * 1994-07-15 1996-01-18 Basf Ag Verwendung heterocyclischer Verbindungen
US5688795A (en) * 1994-11-08 1997-11-18 Syntex (U.S.A.) Inc. 3-(4-phenylpiperazin-1-yl)propyl-amino, thio and oxy!-pyridine, pyrimidine and benzene derivatives as α1 -adrenoceptor antagonists
WO1999003833A1 (en) * 1997-07-15 1999-01-28 Sankyo Company, Limited Piperazine derivatives

Also Published As

Publication number Publication date
NZ506462A (en) 2003-07-25
PT1054868E (pt) 2004-01-30
TR200003220T2 (tr) 2001-04-20
KR100591028B1 (ko) 2006-06-22
US6218396B1 (en) 2001-04-17
ES2209468T3 (es) 2004-06-16
BR9909647A (pt) 2000-11-21
EP1054868A1 (en) 2000-11-29
AU3302599A (en) 1999-09-06
KR20010041115A (ko) 2001-05-15
CZ20003044A3 (cs) 2001-04-11
ATE250580T1 (de) 2003-10-15
CZ294136B6 (cs) 2004-10-13
NO20004141L (no) 2000-10-19
HUP0100781A2 (hu) 2001-08-28
AR014626A1 (es) 2001-03-28
HUP0100781A3 (en) 2002-12-28
PL342339A1 (en) 2001-06-04
IL137954A (en) 2007-06-03
AU766398B2 (en) 2003-10-16
DE69911582D1 (de) 2003-10-30
HK1030776A1 (en) 2001-05-18
CN1121390C (zh) 2003-09-17
IL137954A0 (en) 2001-10-31
NO20004141D0 (no) 2000-08-18
DK1054868T3 (da) 2003-12-22
JP2002503724A (ja) 2002-02-05
NO317103B1 (no) 2004-08-09
WO1999042448A1 (en) 1999-08-26
CN1291188A (zh) 2001-04-11
EP1054868B1 (en) 2003-09-24
TW565555B (en) 2003-12-11
DE69911582T2 (de) 2005-09-15

Similar Documents

Publication Publication Date Title
NO993396L (no) Kinolin- og kinolinforbindelser nyttige i terapi, spesielt i behandlingen av benign prostatisk hyperplasi
AU1316000A (en) Compositions and methods for treating benign prostatic hyperplasia using tocotrienols
AU3011299A (en) Combination therapy for the treatment of benign prostatic hyperplasia
IL141235A0 (en) Combined use of an alpha-adrenoceptor antagonist and amuscarinic antagonist in the treatment of benign prostatic hyperplasi
AU1657097A (en) Use of alpha1-adrenoreceptor antagonists in the prevention and treatment of benign prostatic hyperplasia
EP0855910A4 (en) CONJUGATES USEFUL FOR TREATING BENIN PROSTATIC ADENOMA
ZA991315B (en) Novel substituted pyridino arylpiperazines useful in the treatment of benign prostatic hyperplasia.
ZA983968B (en) Arylsubstituted piperazines useful in the treatment of benign prostatic hyperplasia.
ZA982819B (en) Treatment or prophylaxis of prostatic cancer and benign prostatic hyperplasia with selective estrogn receptor modulators.
AU3896899A (en) Compositions for the treatment of tumors, and uses thereof
ZA991319B (en) Novel phthalimido arylpiperazines useful in the treatment of benign prostatic hyperplasia.
BG104914A (en) Paroxetine maleate
EP0633781A4 (en) COMPOSITIONS AND METHODS FOR TREATING BENIGN PROSTATIC HYPERTROPHY.
AU9128998A (en) Composition and method for the treatment of benign prostatic hyperplasia and prostatitis
HK1049485A1 (en) DithiepinoÄ6,5-BÜpyridines, and related compositions, methods of producing and uses.
EP1140906A4 (en) IMIDAZOLONES AND THEIR USE IN THE TREATMENT OF BENIGN PROSTATIC HYPERPLASIA AND OTHER DISORDERS
AU2002232403A1 (en) Del-1 and benign prostatic hyperplasia
GB9602903D0 (en) Conjugates useful in the treatment of benign prostatic hyperplasia
HK1045506A1 (en) Oxathiepino 6,5- i b /iÜdihydropyridines, and related compositions and methods
GB9810895D0 (en) Combination therapy for the treatment of benign prostatic hyperplasia
AU2002300904A1 (en) Arylsubstituted piperazines useful in the treatment of benign prostatic hyperplasia
ZA988293B (en) Compositions and methods for the treatment of tumor.
ZA200202930B (en) Methods and compositions utilizing quinazolinones.
AU2003204320A1 (en) Heterocycles useful in the treatment of benign prostatic hyperplasia and intermediates thereof
AU2002239466A1 (en) Gene associated with benign prostatic hyperplasia in humans